Form 4 for CAH Cardinal Health
Accepted 2023-11-29 00:00:00 ET · period of report 2023-11-27 · accession 0000721371-23-000112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-29 | 2023-11-27 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M - OptEx | $74.10 | +27.6K | 50.2K | +123% | +$2.05M |
| D | 2023-11-29 | 2023-11-27 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | S - Sale+OE | $106.31 | -36.6K | 35.2K | -51% | -$3.90M |
| DM | 2023-11-29 | 2023-11-27 | CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | M - OptEx | $0.00 | -27.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-11-27 | M | A | 6,279 | $83.19 | 56,471 | D | — | — | |
| 2 | Common | Common Shares | 2023-11-27 | M | A | 15,373 | $66.43 | 71,844 | D | — | — | |
| 3 | Common | Common Shares | 2023-11-27 | S | D | 36,642 | $106.31 | 35,202 | D | — | — | (F2) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.11 to $106.76, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4. |
| 4 | Common | Common Shares | 2023-11-27 | M | A | 5,990 | $84.27 | 50,192 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-11-27 | M | D | 6,279 | $0.00 | 0 | D | $83.19 · — to 2026-08-15 | 6,279 Common Shares | (F4) Stock option vested in three equal installments on August 15, 2017, August 15, 2018, and August 15, 2019. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2023-11-27 | M | D | 15,373 | $0.00 | 0 | D | $66.43 · — to 2027-08-15 | 15,373 Common Shares | (F5) Stock option vested in three equal installments on August 15, 2018, August 15, 2019, and August 15, 2020. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2023-11-27 | M | D | 5,990 | $0.00 | 0 | D | $84.27 · — to 2025-08-15 | 5,990 Common Shares | (F3) Stock option vested in three equal installments on August 15, 2016, August 15, 2017, and August 15, 2018. |